Affiliation:
1. Infectious Disease Division, Department of Medicine, Department of Pathology, Washington University School of Medicine, Saint Louis, Missouri 63110
2. Clinical Microbiology Laboratories, Department of Pathology, Washington University School of Medicine, Saint Louis, Missouri 63110
Abstract
The in vitro activity of HR756, a new semisynthetic cephalosporin, was compared with the activities of cephalothin, cefoxitin, and cefamandole against 1,535 isolates of gram-positive and gram-negative bacteria. HR756 was less active than cephalothin and cefamandole and twofold more active than cefoxitin against
Staphylococcus
. All four of the antibiotics were inactive against the enterococcus group of
Streptococcus
; however, HR756 was the most active antibiotic against the other isolates of
Streptococcus
. HR756 was also more active against isolates of
Enterobacteriaceae
, including 84 to 95% of the isolates resistant to one or more of the other three antibiotics. HR756, at a concentration of 12.5 μg/ml, inhibited 86, 75, and 100% of the isolates of
Pseudomonas aeruginosa
, other
Pseudomonas
species, and
Acinetobacter
, respectively. The minimal inhibitory concentrations and minimal bactericidal concentrations of HR756 were within one twofold dilution for 11 of 21 gram-positive cocci and 119 of 125 gram-negative bacilli tested.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献